By
Michael X Repka, MD, MBA,
Kayla Amodeo, PHD,
David B Glasser, MD,
Sue J Vicchrilli, COT, OCS, OCSR
Webinar - December 8, 2020
01:16:56
The CMS final rule conveys the outcome of our Call to Action to thwart cuts to reimbursement and changes to telemedicine. In this webinar, Academy experts Michael X. Repka, MD, MBA, medical director for governmental affairs; Kayla L. Amodeo, PhD, director of health policy; David B. Glasser, MD, secretary for federal affairs; and Sue Vicchrilli, COT, OCS, OCSR, director, Coding & Reimbursement, dissect the key components of the final rule, including the impact of budget neutrality and the 2021 conversion factor, changes to E/M and Eye visit codes, E/M payments for postop visits, complex care add-on code, AI technology coverage, and telehealth provisions.
Download the slides (PDF 782 KB)
Additional Resources: